Literature DB >> 12466163

Chronic angle-closure with glaucomatous damage: long-term clinical course in a North American population and comparison with an Asian population.

Mohamad Rosman1, Tin Aung, Leonard P K Ang, Paul T K Chew, Jeffrey M Liebmann, Robert Ritch.   

Abstract

PURPOSE: To study the long-term clinical course of North American chronic angle-closure glaucoma (CACG) patients with optic disc damage and visual field loss in the presence of an angle closed at least partially by peripheral anterior synechiae and to compare it with a similar group of Singaporean patients.
DESIGN: A retrospective, interventional case-control study series. PARTICIPANTS: Fifty-one patients (80 eyes) diagnosed with CACG with glaucomatous optic nerve head and visual field damage at a New York hospital from January 1990 through December 1994. All study eyes underwent laser peripheral iridotomy (LPI).
METHODS: The presenting features, management, and subsequent long-term intraocular pressure (IOP) outcome were analyzed and compared with 65 Asian patients (83 eyes) from a Singapore hospital who were similarly diagnosed during the same period. MAIN OUTCOME MEASURES: The long-term outcome after LPI was assessed in terms of IOP and the requirement for additional therapy.
RESULTS: The mean presenting IOP was higher in the Singapore eyes (40 +/- 15 mmHg) compared with the New York eyes (31 +/- 12.5 mmHg). All 80 New York eyes (100%) and 78 of 83 Singapore eyes (94%) required further treatment to control IOP during follow-up. Of the eyes with a subsequent rise in IOP, 33 of 80 eyes (41.3%) compared with 34 of 83 eyes (41.0%) of the Singapore patients were controlled with additional topical medication. Of the New York eyes, 25 of 80 (31.3%) eventually underwent filtering surgery, compared with 44 of 83 (53.0%) in the Singapore study. The other 22 eyes (27.5%) in the New York group went on to additional laser procedures, peripheral iridoplasty, laser trabeculoplasty, or a combination thereof, after which IOPs were controlled and no surgery was required. There was no similar comparison for the Singapore group, because these eyes went directly on to surgery.
CONCLUSIONS: Despite the presence of a patent LPI, most eyes with CACG presenting with elevated IOP and having both optic disc and visual field damage in both populations required further treatment to control IOP. Results in the American population are similar to that reported in Asian patients.

Entities:  

Mesh:

Year:  2002        PMID: 12466163     DOI: 10.1016/s0161-6420(02)01275-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  18 in total

1.  Subsequent Receipt of Interventions for Glaucoma Among a Nationwide Sample of Patients Who Underwent Laser Peripheral Iridotomy.

Authors:  Surbhi Bansal; S Asha Balakrishnan; Taylor Blachley; Jennifer S Weizer; Paul P Lee; Joshua D Stein
Journal:  Am J Ophthalmol       Date:  2015-04-30       Impact factor: 5.258

2.  Evaluation of the efficacy of laser peripheral iridoplasty in reversing the darkroom provocative test result in Chinese patients with primary angle closure status post laser iridotomy.

Authors:  Ping Huang; Ling-Ling Wu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

3.  Effect of Laser Peripheral Iridotomy on Anterior Chamber Angle Anatomy in Primary Angle Closure Spectrum Eyes.

Authors:  Seema Kansara; Lauren S Blieden; Alice Z Chuang; Laura A Baker; Nicholas P Bell; Kimberly A Mankiewicz; Robert M Feldman
Journal:  J Glaucoma       Date:  2016-05       Impact factor: 2.503

4.  Long-term Outcome of Argon Laser Peripheral Iridoplasty in the Management of Plateau Iris Syndrome Eyes.

Authors:  Jeffrey R Peterson; John W Anderson; Lauren S Blieden; Alice Z Chuang; Robert M Feldman; Nicholas P Bell
Journal:  J Glaucoma       Date:  2017-09       Impact factor: 2.503

5.  Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.

Authors:  Xuan Xiao; Long Xue; Lin Ye; Hongzheng Li; Yunzhen He
Journal:  BMC Public Health       Date:  2021-06-04       Impact factor: 3.295

6.  Primary phacoemulsification and intraocular lens implantation for acute primary angle-closure.

Authors:  Wei-Wen Su; Phil Yeong-Fung Chen; Ching-Hsi Hsiao; Henry Shen-Lih Chen
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

7.  Management of angle closure glaucoma.

Authors:  Jovina L S See; Maria Cecilia D Aquino; Joel Aduan; Paul T K Chew
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

8.  Efficacy of goniosynechialysis for advanced chronic angle-closure glaucoma.

Authors:  Guoping Qing; Ningli Wang; Dapeng Mu
Journal:  Clin Ophthalmol       Date:  2012-10-29

9.  Clinical outcomes of peripheral iridotomy in patients with the spectrum of chronic primary angle closure.

Authors:  Ricardo J Cumba; Kundandeep S Nagi; Nicholas P Bell; Lauren S Blieden; Alice Z Chuang; Kimberly A Mankiewicz; Robert M Feldman
Journal:  ISRN Ophthalmol       Date:  2013-06-26

10.  Meta-analysis of randomized controlled trials comparing latanoprost with timolol in the treatment of Asian populations with chronic angle-closure glaucoma.

Authors:  Shi-Ming Li; Ru Chen; Yuan Li; Zhi-Rong Yang; Qiu-Ju Deng; Zheng Zhong; Moh-Lim Ong; Si-Yan Zhan
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.